Transurban Group conducted its 2026 Annual General Meetings for its three entities, focusing on operational updates and community involvement. The Chair acknowledged the traditional owners of the land and highlighted partnerships with First Nations artists on the M7 Motorway in Western Sydney. The meetings also addressed recent local events and provided a platform for security holders to engage directly with the Board. A recording of the meetings will be available online for those who experienced technical difficulties.
Transurban Group's 2026 Annual General Meetings offer context for readers interested in infrastructure and industrial sectors. For readers following Industrials, here is Pluang's market snapshot as of Oct 21, 2026 13:41 WIB: Out of 135 priced US Industrials stocks, 101 rose and 34 fell today. Notably, Northrop Grumman Corporation (NOC) traded at USD 534.09 with a 4.59% gain and a typical hold time of 83 days, contrasting with Eos Energy Enterprises Inc (EOSE) at USD 1.71, down 5.52%, held typically for 17 days. INNIO N.V. (INIO) also rose 4.43% to USD 16.72 with the shortest hold time of 6 days among these movers.
A webinar titled "Ready for AI?" scheduled for October 29, 2026, will discuss how artificial intelligence is reshaping public relations by changing how information is found, evaluated, and shared. Experts will share insights on maintaining message vi...
17a-4 LLC introduced DataParser Hub, an API that enables clients to integrate proprietary messaging and collaboration data into Microsoft 365 Purview and Copilot. This solution supports over 30 data types from platforms like Slack, Zoom, and Webex, a...
IBA has treated the first patient in the C-FLASH-01 clinical trial, the first human study testing ConformalFLASH® proton therapy. This trial, conducted at Penn Medicine with FDA approval, explores the feasibility of using ultra-high dose rate proton ...
IBA has treated the first patient in the C-FLASH-01 clinical trial, testing its ConformalFLASH® proton therapy for head and neck cancer re-irradiation. This trial, led by Penn Medicine and approved by the FDA, explores ultra-high dose rate proton the...
WISeQey Corp. completed its redomiciliation and began trading on Nasdaq and the SIX Swiss Exchange, marking a new phase focused on integrating its quantum cybersecurity, digital identity, and space IoT technologies. Its subsidiary WISeSat.Space also ...
